An ultrasound test may more reliably detect ovarian cancer in premenopausal women than the Risk of Malignancy Index
1. This cohort study found that the IOTA ADNEX ultrasound model at a 10% risk threshold detected more ovarian cancers...
1. This cohort study found that the IOTA ADNEX ultrasound model at a 10% risk threshold detected more ovarian cancers...
1. In this individual-based modeling study, fewer cervical cancer screens for HPV-vaccinated women were the most cost-effective strategy. 2. Fewer...
1. This randomized controlled trial found that, in patients with hormone-receptor-positive, HER2-positive metastatic breast cancer, the addition of palbociclib to...
1. Among patients with previously untreated programmed death-ligand 1 positive, triple-negative breast cancer, first-line sacituzumab govitecan plus pembrolizumab significantly prolonged...
1. AstraZeneca is acquiring Modella AI to embed multimodal foundation models into oncology R&D and strengthen biomarker driven trial strategy....
NVIDIA and Lilly put $1B behind AI as core drug infrastructure During the JPMorgan Healthcare Conference week in mid January...
1. New FDA communication introduces a more flexible, risk‑based chemistry, manufacturing, and controls (CMC) framework for cell and gene therapies,...
1. Surgery-induced weight loss was associated with lower cancer incidence and mortality rates in women with obesity, but not men....
1. In this cohort study, a novel prognostic model was developed to estimate prostate cancer-specific mortality (PCSM) while accounting for...
1. In patients with advanced cancer who are not hypoxemic, high-flow nasal therapy using room air and simple fan therapy...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.